Unknown

Dataset Information

0

Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.


ABSTRACT: FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin), a 5-fluorouracil (5-FU)-based chemotherapy regimen, is one of most common therapeutic regimens for colorectal cancer. However, intestinal mucositis is a common adverse effect for which no effective preventive strategies exist. Moreover, the efficacy and the safety of fecal microbiota transplants (FMT) in cancer patients treated with anti-neoplastic agents are still scant. We investigated the effect of FMT on FOLFOX-induced mucosal injury. BALB/c mice implanted with syngeneic CT26 colorectal adenocarcinoma cells were orally administered FMT daily during and two days after five-day injection of FOLFOX regimen for seven days. Administration of FOLFOX significantly induced marked levels of diarrhea and intestinal injury. FMT reduced the severity of diarrhea and intestinal mucositis. Additionally, the number of goblet cells and zonula occludens-1 decreased, while apoptotic and NF-?B-positive cells increased following FOLFOX treatment. The expression of toll-like receptors (TLRs), MyD88, and serum IL-6 were upregulated following FOLFOX treatment. These responses were attenuated following FMT. The disrupted fecal gut microbiota composition was also restored by FMT after FOLFOX treatment. Importantly, FMT did not cause bacteremia and safely alleviated FOLFOX-induced intestinal mucositis in colorectal cancer-bearing mice. The putative mechanism may involve the gut microbiota TLR-MyD88-NF-?B signaling pathway in mice with implanted colorectal carcinoma cells.

SUBMITTER: Chang CW 

PROVIDER: S-EPMC7013718 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.

Chang Ching-Wei CW   Lee Hung-Chang HC   Li Li-Hui LH   Chiang Chiau Jen-Shiu JS   Wang Tsang-En TE   Chuang Wei-Hung WH   Chen Ming-Jen MJ   Wang Horng-Yuan HY   Shih Shou-Chuan SC   Liu Chia-Yuan CY   Tsai Tung-Hu TH   Chen Yu-Jen YJ  

International journal of molecular sciences 20200108 2


FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin), a 5-fluorouracil (5-FU)-based chemotherapy regimen, is one of most common therapeutic regimens for colorectal cancer. However, intestinal mucositis is a common adverse effect for which no effective preventive strategies exist. Moreover, the efficacy and the safety of fecal microbiota transplants (FMT) in cancer patients treated with anti-neoplastic agents are still scant. We investigated the effect of FMT on FOLFOX-induced mucosal injury. BAL  ...[more]

Similar Datasets

| S-EPMC9499828 | biostudies-literature
| S-EPMC10776634 | biostudies-literature
| S-EPMC5479396 | biostudies-literature
| S-EPMC6699279 | biostudies-other
| S-EPMC9158325 | biostudies-literature
| S-EPMC11316615 | biostudies-literature
| S-EPMC3048158 | biostudies-other
| S-EPMC8298376 | biostudies-literature
| S-EPMC9936653 | biostudies-literature
| S-EPMC8890388 | biostudies-literature